Interstitial lung disease in systemic sclerosis patients may benefit more from anti-reflux therapies than from immunosuppressants.
Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy. Electronic address: manuelefurnari@gmail.com.
Manuele
M
Furnari
Gastroenterology Unit, Department of Internal Medicine, University of Genoa, Genoa, Italy.
Vincenzo
V
Savarino
Gastroenterology Unit, Department of Internal Medicine, University of Pisa, Pisa, Italy.
Nicola
N
de Bortoli
Gastroenterology Unit, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Edoardo
E
Savarino
D005764:Gastroesophageal Reflux; D006801:Humans; D007166:Immunosuppressive Agents; D008168:Lung; D017563:Lung Diseases, Interstitial; D012595:Scleroderma, Systemic
D007166:Immunosuppressive Agents
Gastroesophageal reflux disease; Idiopathic Pulmonary Fibrosis; Interstitial lung disease; Systemic sclerosis